Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3132)
All Articles published online
|
Sep 7, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abaza MSI, Bahman AMA, Al-Attiyah RJ. Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells. World J Gastroenterol 2008; 14(33): 5162-5175 [PMID: 18777593 DOI: 10.3748/wjg.14.5162] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i33/5162.htm |
| Number | Citing Articles |
| 1 |
Prinka Singla, Vijay Luxami, Raja Singh, Vibha Tandon, Kamaldeep Paul. Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies. European Journal of Medicinal Chemistry 2017; 126: 24 doi: 10.1016/j.ejmech.2016.09.093
|
| 2 |
Daniela Cihalova, Jakub Hofman, Martina Ceckova, Frantisek Staud, Gabriele Multhoff. Purvalanol A, Olomoucine II and Roscovitine Inhibit ABCB1 Transporter and Synergistically Potentiate Cytotoxic Effects of Daunorubicin In Vitro. PLoS ONE 2013; 8(12): e83467 doi: 10.1371/journal.pone.0083467
|
| 3 |
Oana-Maria Thoma, Markus F. Neurath, Maximilian J. Waldner. Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.757120
|
| 4 |
Shu Li Shao, Wei Wei Chen, Wei Wei Zhang, Wei Zhao, Feng Ying Li. Effect of ADM on Proliferation and Apoptosis of Human Gastric Cancer Cell SGC-7901. Advanced Materials Research 2012; : 2434 doi: 10.4028/www.scientific.net/AMR.535-537.2434
|
| 5 |
Mathew C. Casimiro, Richard G. Pestell, Erik S. Knudsen. Cancer Therapeutic Targets. 2016; : 1 doi: 10.1007/978-1-4614-6613-0_13-5
|
| 6 |
Serena Vella, Elisa Tavanti, Claudia Maria Hattinger, Marilù Fanelli, Rogier Versteeg, Jan Koster, Piero Picci, Massimo Serra, Dominique Heymann. Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells. PLOS ONE 2016; 11(11): e0166233 doi: 10.1371/journal.pone.0166233
|
| 7 |
Sonal M Manohar. Cyclin-dependent kinases as potential targets for colorectal cancer: past, present and future. Future Medicinal Chemistry 2022; 14(14): 1087 doi: 10.4155/fmc-2022-0064
|
| 8 |
Aanchal Sharma, Manoj Kumar Bhat. Enhancement of Carboplatin- and Quercetin-Induced Cell Death by Roscovitine Is Akt Dependent and p53 Independent in Hepatoma Cells. Integrative Cancer Therapies 2011; 10(4): NP4 doi: 10.1177/1534735411423922
|
| 9 |
Bingyue Zhang, Huiran Niu, Qingqing Cai, Mengqin Liao, Keren Chen, Yaosheng Chen, Peiqing Cong. Roscovitine and Trichostatin A promote DNA damage repair during porcine oocyte maturation. Reproduction, Fertility and Development 2019; 31(3): 473 doi: 10.1071/RD18021
|
| 10 |
Mohamed-Salah Abaza, Raja’a Al-Attiyah, Radhika Bhardwaj, Ghaneim Abbadi, Mathew Koyippally, Mohammad Afzal. Syringic acid fromTamarix aucherianapossesses antimitogenic and chemo-sensitizing activities in human colorectal cancer cells. Pharmaceutical Biology 2013; 51(9): 1110 doi: 10.3109/13880209.2013.781194
|
| 11 |
Javier G. Pizarro, Jaume Folch, Felix Junyent, Ester Verdaguer, Carme Auladell, Carlos Beas-Zarate, Mercè Pallàs, Antoni Camins. Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cells. Apoptosis 2011; 16(5): 536 doi: 10.1007/s10495-011-0583-3
|
| 12 |
Srinivasulu Cherukupalli, Balakumar Chandrasekaran, Rajeshwar Reddy Aleti, Nisar Sayyad, Girish A. Hampannavar, Srinivas Reddy Merugu, Harikrishna Reddy Rachamalla, Rajkumar Banerjee, Rajshekhar Karpoormath. Synthesis of 4,6-disubstituted pyrazolo[3,4-d]pyrimidine analogues: Cyclin-dependent kinase 2 (CDK2) inhibition, molecular docking and anticancer evaluation. Journal of Molecular Structure 2019; 1176: 538 doi: 10.1016/j.molstruc.2018.08.104
|
| 13 |
A Linton, Y Y Cheng, K Griggs, M B Kirschner, S Gattani, S Srikaran, S Chuan-Hao Kao, B C McCaughan, S Klebe, N van Zandwijk, G Reid. An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British Journal of Cancer 2014; 110(2): 510 doi: 10.1038/bjc.2013.731
|
| 14 |
Mathew C. Casimiro, Richard G. Pestell, Erik S. Knudsen. Cancer Therapeutic Targets. 2015; : 1 doi: 10.1007/978-1-4614-6613-0_13-4
|
| 15 |
K. Balci, Y. Akkaya, S. Akyuz, N. Palavan‐Unsal. DFT and MP2 based quantum mechanical calculations and a theoretical vibrational spectroscopic investigation on roscovitine, a potential drug to treat cancers. Journal of Raman Spectroscopy 2011; 42(4): 719 doi: 10.1002/jrs.2774
|
| 16 |
Jakub Hofman, Davoud Ahmadimoghaddam, Lenka Hahnova, Petr Pavek, Martina Ceckova, Frantisek Staud. Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone. Pharmacological Research 2012; 65(3): 312 doi: 10.1016/j.phrs.2011.11.017
|
| 17 |
Mathew C. Casimiro, Richard G. Pestell, Erik S. Knudsen. Cancer Therapeutic Targets. 2017; : 989 doi: 10.1007/978-1-4419-0717-2_13
|
| 18 |
Ajda Çoker Gürkan, Elif Damla Arısan, Pınar Obakan, Narçin Palavan-Ünsal. Inhibition of polyamine oxidase prevented cyclin-dependent kinase inhibitor-induced apoptosis in HCT 116 colon carcinoma cells. Apoptosis 2013; 18(12): 1536 doi: 10.1007/s10495-013-0885-8
|
| 19 |
M.S.I. ABAZA. Augmentation of the anticancer effects of proteasome inhibitors by combination with sodium butyrate in human colorectal cancer cells. Experimental and Therapeutic Medicine 2010; 1(4): 675 doi: 10.3892/etm_00000106
|